Effect of Sepsis Response Team in the Emergency Department

NCT ID: NCT03789838

Last Updated: 2022-05-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

245 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-05-15

Study Completion Date

2018-05-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Does sepsis response team in the emergency department increase the portion of sepsis patient who receive adequate treatment within one hour?

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Does sepsis response team in the emergency department increase the portion of sepsis patient who receive adequate treatment within one hour? The time from the patients arrive at the emergency department to an adequate antibiotic is given, before and after introduction of a sepsis response team, was registered.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sepsis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Before of sepsis rapid response team

Time from arrival at the Emergency Department to antibiotic is administered, before introduction of sepsis response team in the Emergency Department.

No interventions assigned to this group

Sepsis rapid response team

Time from arrival at the Emergency Department to antibiotic is administered, with sepsis response team in the Emergency Department.

Sepsis rapid response team

Intervention Type OTHER

Patients with suspected sepsis is managed by a sepsis rapid response team in a structured manner.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Sepsis rapid response team

Patients with suspected sepsis is managed by a sepsis rapid response team in a structured manner.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with suspected sepsis

Exclusion Criteria

* Patients who was consider not to need antibiotics
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Oslo University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Aleksander Rygh Holten

Consultant Physician

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Aleksander Holten, Phd, MD

Role: PRINCIPAL_INVESTIGATOR

Oslo University Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Oslo University Hospital

Oslo, , Norway

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Norway

References

Explore related publications, articles, or registry entries linked to this study.

Trydal E, Martinsen AB, Beisland F, Jacobsen D, Holten AR. [Structured evaluation on arrival of patients with sepsis and initiation of antibiotics]. Tidsskr Nor Laegeforen. 2019 May 27;139(9). doi: 10.4045/tidsskr.18.0216. Print 2019 May 28. Norwegian.

Reference Type RESULT
PMID: 31140244 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Ulleval sepsis-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

ED Tracking Sheet Implementation
NCT05213923 COMPLETED NA
Comparison of Sepsis Prediction Algorithms
NCT05943938 NOT_YET_RECRUITING